Galectin Therapeutics Inc (GALT) stock
GALTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.98+0.07 (+2.41%)
Close on Nov 18, 2026Market cap $300.53MP/E –Yield –
Galectin Therapeutics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Galectin Therapeutics's pe ratio was 21.0× on Jan 31, 2019.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2019 | Jan 31, 2019 | 21.0× | +6.1 |
| 2018 | Dec 31, 2018 | 14.9× | – |
See a number that looks wrong?